# Evaluate the Noninferiority of Medicines Treating Uninfected Pressure Ulcers.

> **NCT02004626** · PHASE3 · WITHDRAWN · sponsor: **Cristália Produtos Químicos Farmacêuticos Ltda.**

## Conditions studied

- Pressure Ulcer

## Interventions

- **DRUG:** Collagenase
- **DRUG:** Kollagenase

## Key facts

- **NCT ID:** NCT02004626
- **Lead sponsor:** Cristália Produtos Químicos Farmacêuticos Ltda.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-01
- **Primary completion:** 2015-06
- **Final completion:** 2015-09
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02004626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02004626, "Evaluate the Noninferiority of Medicines Treating Uninfected Pressure Ulcers.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02004626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*